KING LUTHER CAPITAL MANAGEMENT CORP - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
KING LUTHER CAPITAL MANAGEMENT CORP ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$850,124
-7.6%
8,346
-8.5%
0.00%
-20.0%
Q2 2023$920,501
-5.4%
9,122
-13.8%
0.01%0.0%
Q1 2023$973,268
+7.3%
10,579
+5.8%
0.01%0.0%
Q4 2022$906,837
+14.5%
9,996
-4.1%
0.01%0.0%
Q3 2022$792,000
-20.2%
10,422
-11.3%
0.01%
-16.7%
Q2 2022$993,000
+21.2%
11,746
+25.8%
0.01%
+50.0%
Q1 2022$819,000
-3.1%
9,334
-3.4%
0.00%0.0%
Q4 2021$845,000
-13.3%
9,666
-18.9%
0.00%
-20.0%
Q3 2021$975,000
-36.8%
11,921
-29.5%
0.01%
-37.5%
Q2 2021$1,543,000
+73.0%
16,909
+62.1%
0.01%
+60.0%
Q1 2021$892,000
-36.2%
10,431
-29.5%
0.01%
-37.5%
Q4 2020$1,398,000
-0.4%
14,800
-8.3%
0.01%
-11.1%
Q3 2020$1,404,000
-11.8%
16,146
-11.4%
0.01%
-18.2%
Q2 2020$1,591,000
+2.1%
18,216
-3.6%
0.01%
-15.4%
Q1 2020$1,558,000
-26.8%
18,896
-15.9%
0.01%
-7.1%
Q4 2019$2,128,000
+233.5%
22,477
+206.3%
0.01%
+180.0%
Q3 2019$638,000
-4.8%
7,3380.0%0.01%0.0%
Q2 2019$670,000
+83.6%
7,338
+93.3%
0.01%
+66.7%
Q1 2019$365,000
+12.0%
3,7960.0%0.00%0.0%
Q4 2018$326,000
-21.8%
3,796
-21.6%
0.00%0.0%
Q3 2018$417,000
+6.6%
4,840
-6.5%
0.00%0.0%
Q2 2018$391,000
+6.8%
5,175
+14.3%
0.00%0.0%
Q1 2018$366,000
-0.3%
4,526
+3.5%
0.00%0.0%
Q4 2017$367,000
-0.8%
4,371
+1.3%
0.00%0.0%
Q3 2017$370,000
-7.3%
4,314
-9.7%
0.00%
-25.0%
Q2 2017$399,000
+10.2%
4,779
-2.0%
0.00%
+33.3%
Q1 2017$362,000
-2.4%
4,879
-4.2%
0.00%
-25.0%
Q4 2016$371,000
-4.4%
5,092
+3.7%
0.00%0.0%
Q3 2016$388,000
-4.7%
4,912
-0.5%
0.00%0.0%
Q2 2016$407,000
+3.6%
4,938
-8.9%
0.00%0.0%
Q1 2016$393,000
-33.4%
5,419
-20.9%
0.00%
-33.3%
Q4 2015$590,000
-10.9%
6,852
-4.9%
0.01%0.0%
Q3 2015$662,000
-9.6%
7,207
-3.2%
0.01%0.0%
Q2 2015$732,000
+0.8%
7,447
+1.1%
0.01%0.0%
Q1 2015$726,000
+6.5%
7,3630.0%0.01%
+20.0%
Q4 2014$682,000
+7.1%
7,363
+8.7%
0.01%0.0%
Q3 2014$637,000
+91.9%
6,772
+84.5%
0.01%
+66.7%
Q2 2014$332,000
-45.8%
3,670
-54.1%
0.00%
-40.0%
Q3 2013$613,000
+8.5%
7,9890.0%0.01%0.0%
Q2 2013$565,0007,9890.01%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders